Since 2011, Myeloma Patients Europe (MPE) has advocated for better treatment, access and care across Europe. As the myeloma landscape and patients’ needs evolve, we remain committed to delivering the best research, tools, programmes and support to tackle the challenges faced by our members and the broader patient community. 

Last year, we spoke with members, patients, carers, clinicians, researchers and other stakeholders to best understand what the greatest unmet needs are in myeloma and what we can do in the next five years to have the largest impact on our community.

We are excited to share our new Strategic Goals, which will drive our work and activities from 2025 – 2030. We are also pleased to introduce our new Values, Mission and Vision, which we believe more clearly describe our principles, our work and our future direction.

We look forward to working with you to achieve our goals and improve the lives of those affected by myeloma.